| 1,001 | HALL, DENISE C.PHILADELPHIA, PA · 19112 | E-DISCOVERY PROCESS PARTNER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,002 | ANDERSON, CHARLES ALLENDURHAM, NC · 27709 | VACCINE KEY ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,003 | CRUZ, CHRISTIAN OMARWASHINGTON, DC · 20004 | PUBLIC POLICY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,004 | CARDELLI, PAULDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,005 | FURUYA, CHRIS A.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,006 | PRANZO, MARIELENADURHAM, NC · 27701 | MEDICAL AFFAIRS HYBRID BASED (ACROSS-O · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,007 | PARKER, DEBRA D.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,008 | BROWN, BRENT WILLIAM GEORGEDURHAM, NC · 27709 | SALES FORCE EFFECTIVENESS (ONCOLOGY) · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,009 | BERGEY, AMANDA SCHROEDERPHILADELPHIA, PA · 19112 | PRODUCT STRATEGY & DEVELOPMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,010 | WEISSER, STEVEN MCOLLEGEVILLE, PA · 19426 | SCIENTIFIC PROJECT LEADERSHIP · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,011 | DEKREY, STEVEN MDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,012 | PECK, KRISTEN NDURHAM, NC · 27709 | RX SALES PRIMARY CARE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,013 | BULCHANDANI, ANILDURHAM, NC · 27709 | PRICING/REIMBURSEMENT - ANIL BULCHANDA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,014 | FANUTTI, JULIE ANNPHILADELPHIA, PA · 19112 | SALES AND/OR MARKETING TRAINING (ONCOL · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,015 | ANDREWS, DARYLDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 1,016 | CHERRY, DENNISROCKY MOUNT, NC · 27801 | MAINTENANCE MECHANIC · GLAXOSMITHKLINE | DCCCC00000935 | 2026-07-19 | $15 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 07/19/2026Filing 2012660 · amendedFEC filing ↗ |
| 1,017 | NELSEN, LINDAWAYNE, PA · 19087 | CLINICAL RESEARCH · GSK | END CITIZENS UNITEDC00573261 | 2026-08-22 | $15 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 2014577FEC filing ↗ |
| 1,018 | CHERRY, DENNISROCKY MOUNT, NC · 27801 | MAINTENANCE MECHANIC · GLAXOSMITHKLINE | DCCCC00000935 | 2026-08-24 | $15 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 08/24/2026Filing 2013581FEC filing ↗ |
| 1,019 | HALL, DENISE C.PHILADELPHIA, PA · 19112 | E-DISCOVERY PROCESS PARTNER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-08-21 | $15 | Primary (P) | Filing 2013228FEC filing ↗ |
| 1,020 | PARKER, DEBRA D.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-08-21 | $15 | Primary (P) | Filing 2013228FEC filing ↗ |